ENTRADA THERAPEUTICS, INC. Share Price Today: Live Updates & Key Insights

ENTRADA THERAPEUTICS, INC. share price today is $11.34, up -5.59%. The stock opened at $11.88 against the previous close of $11.98, with an intraday high of $12.04 and low of $11.25.

ENTRADA THERAPEUTICS, INC. Share Price Chart

ENTRADA THERAPEUTICS, INC.

us-stock
To Invest in {{usstockname}}
us-stock

ENTRADA THERAPEUTICS, INC. Share Price Performance

$11.34 -0.0559(-5.59%) TRDA at 23 Mar 2026 03:33 PM Biotechnology
Lowest Today 11.25
Highest Today 12.04
Today’s Open 11.88
Prev. Close 11.98
52 Week High 13.66
52 Week Low 4.93
Day’s Range: Low 11.25 High 12.04
52-Week Range: Low 4.93 High 13.66
1 day return -
1 Week return -10.92
1 month return +0.57
3 month return +6.98
6 month return +114.78
1 year return +5.0
3 year return -27.18
5 year return -56.3
10 year return -

ENTRADA THERAPEUTICS, INC. Institutional Holdings

Baker Bros Advisors LP 13.25

Mpm Asset Management, LLC 11.44

5AM Venture Management, LLC 10.60

BlackRock Inc 5.34

Vanguard Group Inc 4.26

Wellington Management Company LLP 2.73

Vanguard Total Stock Mkt Idx Inv 2.49

StepStone Group LLC 1.99

iShares Russell 2000 ETF 1.81

Geode Capital Management, LLC 1.67

TCG Crossover Management, LLC 1.53

State Street Corp 1.30

Millennium Management LLC 1.30

Jacobs Levy Equity Management, Inc. 0.95

T. Rowe Price Associates, Inc. 0.94

Morgan Stanley - Brokerage Accounts 0.91

Acadian Asset Management LLC 0.78

Citadel Advisors Llc 0.76

Fidelity Small Cap Index 0.73

Dimensional Fund Advisors, Inc. 0.71

JPMorgan Chase & Co 0.70

Vanguard Institutional Extnd Mkt Idx Tr 0.67

Northern Trust Corp 0.66

Renaissance Technologies Corp 0.66

iShares Russell 2000 Value ETF 0.65

MEDICAL BioHealth EUR Acc 0.46

iShares Biotechnology ETF 0.41

T. Rowe Price Health Sciences 0.41

Royce Capital Small-Cap Inv 0.41

State St Russell Sm/Mid Cp® Indx SL Cl I 0.37

Vanguard Russell 2000 ETF 0.35

Fidelity Extended Market Index 0.33

Schwab US Small-Cap ETF™ 0.30

Royce Small-Cap Value Service 0.23

Multi-Manager Small Cap Eq Strat Inst 0.22

State St Russell Sm Cap® Indx SL Cl I 0.22

iShares Micro-Cap ETF 0.20

Dimensional US Small Cap ETF 0.19

Schwab Small Cap Index 0.18

North Square Dynamic Small Cap I 0.18

ENTRADA THERAPEUTICS, INC. Market Status

Strong Buy: 2

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

ENTRADA THERAPEUTICS, INC. Fundamentals

Market Cap 433.00 M

PB Ratio 1.4169

PE Ratio 0.0

Enterprise Value 189.00 M

Total Assets 377.38 M

Volume 414705

ENTRADA THERAPEUTICS, INC. Company Financials

Annual Revenue FY24:210782000 210.8M, FY23:87165000 87.2M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY24:210782000 210.8M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY24:65626000 65.6M, FY23:-21770000 -21.8M, FY22:-87457000 -87.5M, FY21:-50072000 -50.1M, FY20:-26379000 -26.4M

Quarterly Revenue Q3/2025:1614000 1.6M, Q2/2025:1950000 2.0M, Q1/2025:20558000 20.6M, Q3/2024:19570000 19.6M, Q2/2024:94694000 94.7M

Quarterly Profit Q3/2025:-36747000 -36.7M, Q2/2025:1950000 2.0M, Q1/2025:20558000 20.6M, Q3/2024:18670000 18.7M, Q2/2024:93794000 93.8M

Quarterly Net worth Q3/2025:-44134000 -44.1M, Q2/2025:-43103000 -43.1M, Q1/2025:-17349000 -17.3M, Q3/2024:-14032000 -14.0M, Q2/2024:55031000 55.0M

About ENTRADA THERAPEUTICS, INC. & investment objective

Company Information Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Organisation Biotechnology

Employees 152

Industry Biotechnology

CEO Mr. Dipal Doshi

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ENTRADA THERAPEUTICS, INC. FAQs

What is the share price of ENTRADA THERAPEUTICS, INC. today?

The current share price of ENTRADA THERAPEUTICS, INC. is $11.34.

Can I buy ENTRADA THERAPEUTICS, INC. shares in India?

Yes, Indian investors can buy ENTRADA THERAPEUTICS, INC. shares by opening an international trading and demat account with Motilal Oswal.

How to buy ENTRADA THERAPEUTICS, INC. shares in India?

You can easily invest in ENTRADA THERAPEUTICS, INC. shares from India by:

Can I buy fractional shares of ENTRADA THERAPEUTICS, INC.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ENTRADA THERAPEUTICS, INC.?

ENTRADA THERAPEUTICS, INC. has a market cap of $433.00 M.

In which sector does ENTRADA THERAPEUTICS, INC. belong?

ENTRADA THERAPEUTICS, INC. operates in the Biotechnology sector.

What documents are required to invest in ENTRADA THERAPEUTICS, INC. stocks?

To invest, you typically need:

What is the PE and PB ratio of ENTRADA THERAPEUTICS, INC.?

The PE ratio of ENTRADA THERAPEUTICS, INC. is N/A and the PB ratio is 1.42.